Characterization of antimicrobial peptide WAM-1 and its interactions with clinical isolates of Acinetobacter baumannii
FEMS Microbiology Letters · 07.01.2026 · 373
DOI: 10.1093/femsle/fnag062 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEMS Microbiology Letters, online erschienen am 26.05.2026. Verfasst von Haley Channell und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine,Mercer University, Columbus, GA 31901, USA. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Antimicrobial Peptides, Anti-Bacterial Agents, Antimicrobial Cationic Peptides. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Mercer University.
Abstract (Originalsprache)
Acinetobacter baumannii, a prominent nosocomial pathogen, commonly causes life-threatening disease in immunocompromised individuals with mortality rates approaching 35%. Known for its multidrug resistance, studies investigating antimicrobial peptides (AMPs) have proven promising. We have previously shown that the AMP WAM-1 exhibits potent bactericidal activity against A. baumannii, but its full therapeutic value and mechanism of action have not yet been elucidated. To evaluate the potential clinical relevance of WAM-1, we characterized its antibacterial effects, inhibition by lipopolysaccharide (LPS), and whether treatment with WAM-1 induced resistance in A. baumannii. Additionally, we explored WAM-1’s mechanism of action by visualizing structural changes induced by treatment with WAM-1 and evaluating permeabilization of the bacterial outer membrane. The activity of WAM-1 was comparable to that of efficacious antibiotics and was not inhibited by the presence of exogenous LPS. Scanning electron microscopy showed evidence of membrane disruption, cellular content leakage, and cell lysis, indicating damage to the bacterial outer membrane, and depolarization of the membrane was observed. WAM-1 was found to induce resistance more slowly than tested antibiotics. Overall, our data indicates that WAM-1 may be a promising therapeutic option for A. baumannii infections and may act, at least in part, by damaging the outer membrane.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine,Mercer University, Columbus, GA 31901, USA.
- Department of Family Medicine, Piedmont Columbus Regional-Midtown, Columbus, GA 31901, USA.
- Department of Biology, Columbus State University, Columbus, GA 31907, USA.
- School of Medicine,Wake Forest University,Charlotte, NC 28204, USA.
ORCID-Profile: Lauren B King
Förderung
- Mercer University
Zitieren
APA
Channell, H., Young, L., Wood, M., & King, L. B. (2026). Characterization of antimicrobial peptide WAM-1 and its interactions with clinical isolates of Acinetobacter baumannii. FEMS Microbiology Letters, 373. https://doi.org/10.1093/femsle/fnag062
Vancouver
Channell H, Young L, Wood M, King LB. Characterization of antimicrobial peptide WAM-1 and its interactions with clinical isolates of Acinetobacter baumannii. FEMS Microbiology Letters. 2026;373. doi:10.1093/femsle/fnag062
BibTeX
@article{Channell2026,
author = {Channell, Haley and Young, Lynsey and Wood, Martin and King, Lauren B},
title = {Characterization of antimicrobial peptide WAM-1 and its interactions with clinical isolates of Acinetobacter baumannii},
journal = {FEMS Microbiology Letters},
year = {2026},
volume = {373},
doi = {10.1093/femsle/fnag062}
}
EUVIMED